First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This research is designed to determine if experimental treatment with AZD9793, a T cell-engaging antibody that targets GPC3, is safe, tolerable and has anti-cancer activity in patients with advanced or metastatic solid tumours which are GPC3+.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzony nowotwór z markerem GPC3 (badanie laboratoryjne)
- •Co najmniej jeden widoczny guz do zmierzenia
- •Dobry stan ogólny pacjenta (ECOG 0-1)
- •Przewidywana długość życia co najmniej 12 tygodni
- •Prawidłowe funkcje narządów i szpiku kostnego
- •U pacjentów z rakiem wątroby: zaawansowana choroba niezdatna do zabiegu chirurgicznego
- •Wcześniejsze leczenie systemowe (dla raka wątroby)
✗ Disqualifies
- •Nieustąpione efekty uboczne z poprzedniego leczenia (stopień 2 i wyżej)
- •Wyjątki: utrata pigmentacji skóry, uszkodzenie nerwów, wypadanie włosów, zaburzenia hormonalne kontrolowane lekami zastępczymi są dopuszczalne
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 13, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (21)
Research Site
La Jolla, United States
Research Site
Los Angeles, United States
Research Site
Baltimore, United States
Research Site
Boston, United States
Research Site
St Louis, United States
Research Site
Hackensack, United States
Research Site
Houston, United States
Research Site
Chengdu, China
Research Site
Guangzhou, China
Research Site
Harbin, China
Research Site
Shanghai, China
Research Site
Pokfulam, Hong Kong
Research Site
Shatin, Hong Kong
Research Site
Kashiwa, Japan
Research Site
Yokohama, Japan
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Barcelona, Spain
Research Site
Pamplona, Spain
Research Site
Taipei, Taiwan
Research Site
Taoyuan, Taiwan
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.